Involvement of the peripheral nervous system in multiple sclerosis;Sclérose en plaques et atteinte du système nerveux périphérique

Revue Neurologique

Volumn 160, Issue 12, 2004, Pages 1159-1163

  Couratier, P ^a,b   Boukhris, S ^a   Magy, L ^a   Traore H ^a   Vallat, J M ^a  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Multiple sclerosis; Myelin; Peripheral nervous system

Indexed keywords

MYELIN;

ANTIGENICITY; CENTRAL NERVOUS SYSTEM; COMORBIDITY; DEMYELINATING DISEASE; ELECTROPHYSIOLOGY; MONONEUROPATHY; MULTIPLE SCLEROSIS; MYELINATED NERVE; NEUROPATHOLOGY; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; PLASTICITY; POLYNEUROPATHY; RADICULOPATHY; REVIEW;

EID: 11144230349     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(04)71160-1     Document Type: Review

References (53)

1. ARIAS M, REQUENA J, PEREIRO I, CABELLO A. (1992). Multiple sclerosis and hypertrophic demyelinating neuropathy. J Neurol Neurosurg Psychiatry, 55: 857.
2. BAUMANN N, PHAM-DINH N. (2001). Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev, 81: 871-927.
3. BENTES C, DE CARVALHO M, DE SA J, LUIS ML. (1999). Chronic steadily progressive central and peripheral predominantly motor demyelination, involving the cranial nerves, responsive to immunoglobulins. Electromyogr Clin Electrophysiol, 39: 33-37.
4. BEST PV. (1985). Acute polyradiculoneuritis associated with demyelinated plaques in the central nervous system: report of a case. Acta Neuropathologica, 67: 230-234.
5. BLACK JA, FJELL J, DIB-HAJJ S, et al. (1999). Abnormal expression of SNS/PN3 sodium channel in cerebellar Purkinje cells following loss of myelin in the Taiep rat. Neuroreport, 21: 870-884.
6. BLACK JA, DIB-HAJJ S, BAKER D, NEWCOMBE J, CUZNER ML, WAXMAN SG. (2000). Sensory neuron specific sodium channel SNS is abnormally expressed in the brains of mice with experimental allergic encephalomyelitis and humans with multiple sclerosis. Proc Natl Acad Sci USA, 97: 11598-11602.
7. BLAKEMORE WF. (1975). Remyelination by Schwann cells of axons demyelinated by intraspinal injection of 6-aminonicotinamide in the rat. J Neurocytol, 4: 745-757.
8. BORNKE C, PRZUNTEK H, POSTERT T, SCHWECHHEIMER K, BUTTNER T. (1999). Atypical multiple sclerosis presenting as chronic-progressive encephalomyelitis with polyneuritis and recurrent aseptic meningitis. J Neurol, 246: 136-139.
9. BRADY ST, WITT AS, KIRKPATRICK LL, DE WAEGH SM, READHE ADC, TU PH LEE VM. (1999). Formation of compact myelin is required for maturation of the axonal cytoskeleton. J Neurol Sci, 19: 7278-7288.
10. BRINKMEIER H, AULKEMEYER P, WOLLINSKY KH, RÜDEL R. (2000). An endogenous pentapeptide acting as a sodium channel blocker in inflammatory autoimmune disorders of the central nervous system. Nat Med, 6: 738-739.
11. v1.6 is localized at nodes of Ranvier, dendrites, and synapses. Proc Natl Acad Sci USA, 97: 5616-5620.
12. CAPELLO E, ROCCATAGLIATA L, SCHENONEA, et al. (2000). Acute axonal form of Guillain-Barré syndrome in a multiple sclerosis patient: chance association or linked disorders? Eur J Neurol, 7: 223-225.
13. CONFAVREUX C, MOREAU T, JOUVET A, TOMMASI M, AYMARD G. (1993). Association of amyotrophic lateral sclerosis and multiple sclerosis. Rev Neurol (Paris), 149: 351-353.
14. CUMMINS TR, RENGANATHAN M, STYS PK, et al. (2003). The pentapeptide QYNAD does not block voltage-gated sodium channels. Neurology, 60: 224-229.
15. DRULOVIC J, DOZIC S, LEVIC Z, et al. (1998). Unusual association of multiple sclerosis and tomaculous neuropathy. J Neurol Sci, 157: 217-222.
16. EISEN A, YUFE R, TROP D, CAMPBELL I. (1978). Reduced neuromuscular transmission safety factor in multiple sclerosis. Neurology, 28: 598-602.
17. EISEN A, PATY D, HOIRCH M. (1982). Altered supernormality in multiple sclerosis peripheral nerve. Muscle Nerve, 1982: 411-414.
18. FEASBY TE, HAHN AF, KOOPMAN WJ, LEE DH. (1990). Central lesions in chronic inflammatory demyelinating polyneuropathy: an MRI study. Neurology, 40: 476-478.
19. FISCHER M, LONG RR, DRACHMAN DA. (1983). Hand muscle atrophy in multiple sclerosis. Arch Neurol, 40: 811-815.
20. FORRESTER C, LASCELLES RG. (1979). Association between polyneuritis and multiple sclerosis. J Neurol Neurosurg Psychiatry, 42: 864-866.
21. GASTAUD JL, BARTOLOMEI F. (1994). Mills' syndrome: ascending (or descending) progressive hemiplegia: a hemiplegic form of primary lateral sclerosis? J Neurol Neurosurg Psychiatry, 57: 1280-1281.
22. GIROUD M, GUARD O, AUDRY D, SOICHOT P, DUMAS R. (1985). An unusual manifestation of multiple sclerosis. Ann Med Interne (Paris), 136: 566-571.
23. HOPF HC, EYSHOLDT M. (1978). Impaired refractory periods of peripheral sensory nerves in multiple sclerosis. Ann Neurol, 4: 499-501.
24. LAGUENY A, ARNAUD A, LE MASSON G, BURBAUD P, DELIAC P, MARTHAN R. (1998). Study of central and peripheral conductions to the diaphragm in patients with definite multiple sclerosis. Electromyogr Clin Neurophysiol, 38: 333-342.
25. LASSMANN H, BUDKA H, SCHNABERTH G. (1981). Inflammatory demyelinating polyradiculitis in a patient with multiple sclerosis. Arch Neurol, 38: 99-102.
26. LAVALLEE P, APARTIS E, VIDAL JS, VIDAILHET M, DERKINDEREN P. (2001). Acute motor radiculopathy as a first symptom of MS: anatomic-radiological correlation. Neurology, 56: 1603-1604.
27. MALIN JP, POBURSKI R, REUSCHE E. (1986). Clinical variants of amyotrophic lateral sclerosis: hemiplegic type of ALS and Mills syndrome. A critical review. Fortschr Neurol Psychiatr, 54: 101-105.
28. MENDELL JR, KOLKIN S, KISSEL JT, WEISS KL, CHAKERES DW, RAMMOHAN KW. (1987). Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology, 37: 1291-1294.
29. NADKARNI N, LISAK RP. (1993). Guillain-Barré syndrome (GBS) with bilateral optic neuritis and central white matter disease. Neurology, 43: 842-843.
30. OGATA J, FEIGIN I. (1975). Schwann cells and regenerated peripheral myelin in multiple sclerosis: an ultrastructural study. Neurology, 25: 713-716.
31. ORMEROD IEC, WADDY HM, KERMODE AG, MURRAY NMF, THOMAS PK. (1990). Involvement of the central nervous system in chronic inflammatory demyelinating polyneuropathy: a clinical, electrophysiological and magnetic resonance imaging study. J Neurol Neurosurg Psychiatry, 53: 789-793.
32. PANAGOPOULOS G, KING RH, GABRIEL G, era/. (1989). Morphometric and freeze-fracture studies on peripheral nerve in shiverer mice. J Comp Neurol, 256: 337-344.
33. PENDER MP. (1988). The pathophysiology of acute experimental allergic encephalomyelitis induced by whole spinal cord in the Lewis rat. J Neurol Sci, 84: 209-222.
34. PENDER MP. (1989). The pathophysiology of myelin basic protein induced acute experimental allergic encephalomyelitis in the Lewis rat. J Neurol Sci, 86: 277-289.
35. POLIAK S, GOLLAN L, MARTINEZ R, et al. (1999). Caspr2, a new member of the neurexin superfamily is localized at the juxtaparanodes of myelinated axons and associates with K+ channels. Neuron, 24: 1037-1047.
36. POLLOCK M, CALDER C, ALLPRESS S. (1977). Peripheral nerve abnormality in multiple sclerosis. Ann Neurol, 2: 41-48.
37. PRIVAT A, JACQUE C, BOURRE JM, DUPOUEY P, BAUMANN N. (1979). Absence of the major dense line in myelin of the mutant shiverer. Neurosci Lett, 12: 107-112.
38. RATCLIFFE CF, WESTENBROEK RE, CURTIS R, CATTERALL WA. (2001). Channel sodium beta 1 and beta 3 subunits associate with neurofascin through their extracellular immunoglobulin-like domain. J Cell Biol, 154: 427-437.
39. RIO J, NOS C, TINTORE M, MARZO ME, MONTALBAN X. (1997). Recurrent Guillain-Barré syndrome and CNS demyelination. J Neurol Neurosurg Psychiatry, 63: 688-689.
40. RO YI, ALEXANDER CB, OH SJ. (1983). Multiple sclerosis and hypertrophic demyelinating peripheral neuropathy. Muscle Nerve, 6: 312-316.
41. ROSENBERG NL, BOURDETTE D. (1983). Hypertrophic neuropathy and multiple sclerosis. Neurology, 33: 1361-1364.
42. RUBIN M, KARPATI G, CARPENTER S. (1987). Combined central and peripheral myelinopathy. Neurology, 37: 1287-1290.
43. SCHOENE WC, CARPENTER S, BEHAN PO, GESCHWIND N. (1977). Onion bulb formations in the central and peripheral nervous system in association with multiple sclerosis and hypertrophic polyneuropathy. Brain, 100: 755-773.
44. SHEFNER JM, CARTER JL, KRARUP C. (1992a). Peripheral sensory abnormalities in patients with multiple sclerosis. Muscle Nerve, 15: 73-76.
45. SHEFNER JM, MACKIN GA, DAWSON DM. (1992b). Lower motor neuron dysfunction in patients with multiple sclerosis. Muscle Nerve, 15: 1265-1270.
46. SINDOU P, ANANI T, GARBAY B, COURATIER P, LAGRANGE E, VALLAT JM. (1999). Implications des protéines myéliniques dans les neuropathies héréditaires. Rev Neurol (Paris), 155: 97-110.
47. STRÄHUBER A. (1903). Ueber degenerations-und proliferationsvorgange bei multipler sklerose des nervensystems. Beitr Z Path Anat U Z Alig Pathol, 33: 409.
48. THOMAS PK, WALKER WH, RUDGE P, et al. (1987). Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination. Brain, 110: 53-76.
49. TRAPANI GD, CARNEVALE A, CIOFFI RP, MASSARO AR, PROFICE P. (1996). Multiple sclerosis associated with peripheral demyelinating neuropathy. Clin Neuropathol, 15: 135-138.
50. WAXMAN SG. (1993). Peripheral nerve abnormalities in multiple sclerosis. Muscle Nerve, 16: 1-5.
51. WAXMAN SG. (2001). Acquired channelopathies in nerve injury and MS. Neurology, 56: 1621-1627.
52. WEIR AI, HANSEN S, BALLANTYNE JP. (1980). Motor unit potential abnormalities in multiple sclerosis: further evidence for peripheral nervous system defect. J Neurol Neurosurg Psychiatry, 43: 999-1004.
53. ZEE PC, COHEN BA, WALCZAK T, JUBELT B. (1991). Peripheral nervous system involvement in multiple sclerosis. Neurology, 41: 457-460.